Showing results (21-30 of 281) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|April 20, 2013
Clinical implementation of pharmacogenetics: more than one gene at a timeJ A Johnson, T E Klein, M V RellingClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Strategies for enzyme/prodrug cancer therapyG Xu, H L McLeodBritish Journal of Clinical Pharmacology|May 1, 1996
Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British populationJ McMurrough, H L McLeodEuropean Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?G Milano, H L McLeodClinical Colorectal Cancer|November 27, 2002
Thymidylate synthase pharmacogenetics in colorectal cancerS Marsh, H L McLeodJournal of Chromatography. B, Biomedical Sciences and Applications|July 16, 1999
Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detectionX Cai, M H Woo, M J Edick, et al.Pharmacotherapy|September 1, 1996
CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosisJ A Bosso, Q Liu, W E Evans, et al.Clinical Pharmacology and Therapeutics|March 3, 2007
Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphismT S Jones, W Yang, W E Evans, et al.Blood|September 15, 1996
Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cellsC L Chen, J C Fuscoe, Q Liu, et al.Pageof 29